|
ZC3H11A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.008600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.267400E-01 |
| Normal-vs-Stage2 |
8.504400E-01 |
| Normal-vs-Stage3 |
8.373400E-01 |
| Normal-vs-Stage4 |
7.660400E-01 |
| Stage1-vs-Stage2 |
7.007000E-01 |
| Stage1-vs-Stage3 |
5.891600E-01 |
| Stage1-vs-Stage4 |
5.476000E-01 |
| Stage2-vs-Stage3 |
9.613200E-01 |
| Stage2-vs-Stage4 |
6.878800E-01 |
| Stage3-vs-Stage4 |
7.083400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.125200E-01 |
| Normal-vs-AfricanAmerican |
7.105000E-01 |
| Normal-vs-Asian |
4.522600E-01 |
| Caucasian-vs-AfricanAmerican |
8.344400E-01 |
| Caucasian-vs-Asian |
6.616000E-01 |
| AfricanAmerican-vs-Asian |
7.033400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.206000E-01 |
| Normal-vs-Female |
9.490200E-01 |
| Male-vs-Female |
6.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.695400E-01 |
| Normal-vs-Extreme_Weight |
3.261400E-01 |
| Normal-vs-Obese |
7.875400E-01 |
| Normal-vs-Extreme_Obese |
5.286800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.983600E-01 |
| Normal_Weight-vs-Obese |
5.106000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.486000E-01 |
| Extreme_Weight-vs-Obese |
2.119200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.843800E-01 |
| Obese-vs-Extreme_Obese |
5.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.629600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.516000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.086200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.821600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.193600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.839200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.903900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.618800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.677700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.575200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.792400E-01 |
| Normal-VS-Type2 PRCC |
2.312300E-02 |
| Normal-VS-KIRP CIMP |
7.000000E-01 |
| Normal-VS-Unclassified PRCC |
9.131000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.354800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.839400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.684000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.386780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.662500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.242000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.884200E-02 |
| Normal-vs-N1 |
1.767820E-01 |
| Normal-vs-N2 |
7.659200E-01 |
| N0-vs-N1 |
1.634270E-02 |
| N0-vs-N2 |
5.336600E-01 |
| N1-vs-N2 |
4.554600E-01 |
|
|
